Literature DB >> 12023625

Porcine livers perfused with human blood mount a graft-versus-"host" reaction.

Michael A Rees1, Andrew J Butler, Hugh F S Davies, Eleanor Bolton, Derek G D Wight, Jeremy Skepper, David J G White, Peter J Friend.   

Abstract

BACKGROUND: A major focus of xenotransplantation research is the interaction between human immune effector mechanisms and porcine tissues. We present evidence that a transplanted porcine organ might also mount a significant immune response to a human recipient.
METHODS: Isolated porcine livers were perfused with fresh human blood. Plasma samples were analyzed for complement production by reverse CH50 analysis. ELISA was used to determine the amount and class of porcine immunoglobulin in human blood after xenoperfusion. Flow cytometry was used to determine the specificity and class of porcine immunoglobulin in human blood after xenoperfusion and to determine whether porcine immunoglobulins had bound to the human lymphocytes in the blood perfusing the porcine livers. Electron microscopy was used to evaluate the interaction of porcine Kupffer cells and human erythrocytes.
RESULTS: Over the course of 72 hr of extracorporeal perfusion of porcine livers with human blood, the hematocrit fell progressively to as low as 2.5% of starting values, a phenomenon not seen in experiments using porcine blood. We have demonstrated both porcine complement and immunoglobulin in the human blood after xenoperfusion. The porcine antibodies in the human blood have specificity for human lymphocyte antigens. In fact, with increasing duration of perfusion, 40% of the xenoperfusions showed increasing titers of porcine antibodies with specificity for human lymphocyte antigens suggesting a response by primed porcine lymphocytes. However, the majority of erythrocytes are extracted directly by Kupffer cells in the liver.
CONCLUSIONS: These data demonstrate the ability of porcine livers to generate both a humoral and cellular graft versus host response to human cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023625     DOI: 10.1097/00007890-200205150-00016

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  A human-specific mutation limits nonhuman primate efficacy in preclinical xenotransplantation studies.

Authors:  Joshua P Waldman; Linda G Brock; Michael A Rees
Journal:  Transplantation       Date:  2014-02-27       Impact factor: 4.939

2.  Blocking porcine sialoadhesin improves extracorporeal porcine liver xenoperfusion with human blood.

Authors:  Joshua P Waldman; Thomas Vogel; Christopher Burlak; Constantin Coussios; Javier Dominguez; Peter Friend; Michael A Rees
Journal:  Xenotransplantation       Date:  2013-07-04       Impact factor: 3.907

3.  Up to 9-day survival and control of thrombocytopenia following alpha1,3-galactosyl transferase knockout swine liver xenotransplantation in baboons.

Authors:  Karen Kim; Christian Schuetz; Nahel Elias; Gregory R Veillette; Isaac Wamala; Manish Varma; R Neal Smith; Simon C Robson; A Benedict Cosimi; David H Sachs; Martin Hertl
Journal:  Xenotransplantation       Date:  2012 Jul-Aug       Impact factor: 3.907

Review 4.  Immunobiology of liver xenotransplantation.

Authors:  Burcin Ekser; Christopher Burlak; Joshua P Waldman; Andrew J Lutz; Leela L Paris; Massimiliano Veroux; Simon C Robson; Michael A Rees; David Ayares; Bruno Gridelli; A Joseph Tector; David Kc Cooper
Journal:  Expert Rev Clin Immunol       Date:  2012-09       Impact factor: 4.473

5.  Porcine sialoadhesin: a newly identified xenogeneic innate immune receptor.

Authors:  L G Brock; P L Delputte; J P Waldman; H J Nauwynck; M A Rees
Journal:  Am J Transplant       Date:  2012-09-07       Impact factor: 8.086

6.  N-glycolylneuraminic acid knockout reduces erythrocyte sequestration and thromboxane elaboration in an ex vivo pig-to-human xenoperfusion model.

Authors:  Arielle Cimeno; Wessam Hassanein; Beth M French; Jessica M Powell; Lars Burdorf; Olga Goloubeva; Xiangfei Cheng; Dawn M Parsell; Jagdeece Ramsoondar; Kasinath Kuravi; Todd Vaught; Mehmet C Uluer; Emily Redding; Natalie O'Neill; Christopher Laird; Alena Hershfeld; Ivan Tatarov; Kathryn Thomas; David Ayares; Agnes M Azimzadeh; Richard N Pierson; Rolf N Barth; John C LaMattina
Journal:  Xenotransplantation       Date:  2017-09-22       Impact factor: 3.907

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.